Cargando…

Anticoagulation Management in High Bleeding-Risk ECMO in Adults

Detalles Bibliográficos
Autores principales:	De Paulis, Stefano, Cavaliere, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020579/ https://www.ncbi.nlm.nih.gov/pubmed/35463781 http://dx.doi.org/10.3389/fcvm.2022.884063

Ejemplares similares

Emergency Cardiac Surgery in Patients on Direct Oral Anticoagulants
por: De Paulis, Stefano, et al.
Publicado: (2022)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Performance of the ABC-bleeding risk score for assessing major bleeding risk in Chinese patients with atrial fibrillation on oral anticoagulation therapy: A real-world study
por: Wang, Yu-Feng, et al.
Publicado: (2022)

Is it time to switch to bivalirudin for ECMO anticoagulation?
por: Navaei, Amir, et al.
Publicado: (2023)

Bleeding Risk Profile in Patients on Oral Anticoagulation Undergoing Percutaneous Coronary Interventions: A Prospective 24 Months Cohort Study
por: Schukraft, Sara, et al.
Publicado: (2021)

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
por: Fox, Keith A A, et al.
Publicado: (2017)

Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock
por: Tsangaris, Adamantios, et al.
Publicado: (2021)

Bleeding During Veno-Venous ECMO: Prevention and Treatment
por: Kalbhenn, Johannes, et al.
Publicado: (2022)

The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding
por: Rajsic, Sasa, et al.
Publicado: (2022)

Mitral Regurgitation and Body Mass Index Increase the Predictability of Perioperative Bleeding in Anticoagulated Patients With Nonvalvular Atrial Fibrillation
por: Huang, Hao, et al.
Publicado: (2022)

Association Between the Use of Pre- and Post-thrombolysis Anticoagulation With All-Cause Mortality and Major Bleeding in Patients With Pulmonary Embolism
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Massive hemoptysis bridged with VV ECMO: A case report
por: Ryan, Dylan, et al.
Publicado: (2022)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
por: Rohla, Miklos, et al.
Publicado: (2019)

Effectiveness and safety of oral anticoagulant therapy in patients with atrial fibrillation with prior gastrointestinal bleeding: A systematic review and meta-analysis
por: Zhao, Jie, et al.
Publicado: (2022)

Ischemic and Bleeding Outcomes According to the Academic Research Consortium High Bleeding Risk Criteria in All Comers Treated by Percutaneous Coronary Interventions
por: Doomun, Daphné, et al.
Publicado: (2021)

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023)

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy
por: de Breet, C. P. D. M., et al.
Publicado: (2021)

Comparison of the Efficacy of ECMO With or Without IABP in Patients With Cardiogenic Shock: A Meta-Analysis
por: Zeng, Ping, et al.
Publicado: (2022)

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Temporal trends in anticoagulation management for US active duty personnel with atrial fibrillation
por: Keithler, Andrea Nichole, et al.
Publicado: (2022)

Platelet Phenotype and Function in the Setting of Pediatric Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review
por: Yaw, Hui Ping, et al.
Publicado: (2019)

New warfarin anticoagulation management model after heart valve surgery: rationale and design of a prospective, multicentre, randomised trial to compare an internet-based warfarin anticoagulation management model with the traditional warfarin management model
por: Zhu, Zhihui, et al.
Publicado: (2019)

Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants—A nationwide cohort study
por: Wu, Hsin-Hsu, et al.
Publicado: (2022)

Clinical Features and Risk Factors Analysis for Hemorrhage in Adults on ECMO
por: Hu, Wenwen, et al.
Publicado: (2021)

High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin
por: Olivieri, Oliviero, et al.
Publicado: (2022)

A Comparative Study of the Clinical Benefits of Rivaroxaban and Warfarin in Patients With Non-valvular Atrial Fibrillation With High Bleeding Risk
por: Liu, Peng-Hui, et al.
Publicado: (2022)

How reliable is perioperative anticoagulant management? Determining guideline compliance and practice variation by a retrospective patient record review
por: Moesker, Marco J, et al.
Publicado: (2019)

Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study
por: Lunde, Elin Danielsen, et al.
Publicado: (2021)

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?
por: Liu, Xuyang, et al.
Publicado: (2022)

Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study
por: Peng, Xiaoping, et al.
Publicado: (2022)

Suture-based vs. pure plug-based vascular closure devices for VA-ECMO decannulation–A retrospective observational study
por: Scherer, Clemens, et al.
Publicado: (2023)

Clinical characteristics and risk factors of in-hospital gastrointestinal bleeding in patients with acute myocardial infarction
por: Zhong, Liang, et al.
Publicado: (2022)

Risk factors of gastrointestinal bleeding after cardiopulmonary bypass in children: a retrospective study
por: Li, Zheng-Qing, et al.
Publicado: (2023)

Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis
por: Grover, Steven P., et al.
Publicado: (2022)

Comparison of the outcomes of warfarin therapy and economics by online and offline anticoagulation management models: protocol for a randomised controlled trial
por: Xia, Xiaotong, et al.
Publicado: (2019)

Effectiveness of Direct Oral Anticoagulants in Obese Adults With Atrial Fibrillation: A Systematic Review of Systematic Reviews and Meta-Analysis
por: Shaikh, Fahad, et al.
Publicado: (2021)

Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study
por: Na, Kun, et al.
Publicado: (2023)

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
por: Choi, Ju Hee, et al.
Publicado: (2022)

Comparative Risks of Fracture Among Direct Oral Anticoagulants and Warfarin: A Systematic Review and Network Meta-Analysis
por: Tsai, Sung Huang Laurent, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_smmibpuqtfj8dbec54e8kumm99